# The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.

Study · id `cardio:ct-nct07649109` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07649109](<https://clinicaltrials.gov/study/NCT07649109>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07649109

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 450 participants.

## Technical summary

Registry record NCT07649109. Randomized; no masking; primary purpose treatment. Start 2025-10-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT07649109, source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)
- Started: 2025-10-01 (actual) (ClinicalTrials.gov record NCT07649109, source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07649109, source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07649109, source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT07649109, source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07649109-2026-06-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.
- Acronym: AHRE
- Condition: Subclinical Atrial Fibrillation
- Condition: Cardiac Arrhythmias
- Intervention (Other): Early Rhythm Control Strategy
- Intervention (Other): Usual Care
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)

## Provenance

Content hash: d00c035ce479c0a9b1cc95096ed28c85e36d3fb1f4e39108454fd18cada92b0a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
